Everand Logo

Welcome to Everand!

  • Discover millions of ebooks, audiobooks, and so much more with a free trial

    Only $11.99/month after trial. Cancel anytime.

    Unavailable
    Analogue-based Drug Discovery III
    Unavailable
    Analogue-based Drug Discovery III
    Unavailable
    Analogue-based Drug Discovery III
    Ebook765 pages7 hours

    Analogue-based Drug Discovery III

    By János Fischer

    3.5/5

    ()

    Currently unavailable

    Currently unavailable

    About this ebook

    Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs.
    The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and -- together with the previous volumes -- constitutes the first systematic approach to drug analogue development.
    LanguageEnglish
    PublisherWiley
    Release dateOct 15, 2012
    ISBN9783527651108
    Unavailable
    Analogue-based Drug Discovery III

    Related to Analogue-based Drug Discovery III

    Related ebooks

    Medical For You

    View More
    View More

    Related podcast episodes

    Related articles

    • Article

      Opinion: Synthetic Control Arms Can Save Time And Money In Clinical Trials

      Feb 5, 2019

      Synthetic control arms aren't the solution to all of the challenges facing randomized trials, but they represent a great way for drug development companies to start using real-world evidence.

      4 min read

    • Article

      Opinion: Biogen’s Good News On Aducanumab Could ‘Open The Floodgates’ For Alzheimer’s Drugs

      Oct 23, 2019

      After pulling the plug on aducanumab in March, Biogen's announcement that the drug works is likely to cause whiplash among some Alzheimer's patients, researchers, and investors.

      3 min read

    • Article

      Crystalized ‘Happiness’ Receptor Sheds Light On Drug Side Effects

      Aug 21, 2018

      By crystalizing a serotonin receptor bound to several common compounds, researchers have discovered how slightly different drugs can cause severe side effects or none at all. The findings should accelerate the design of safer and more effective medic

      3 min read

    • Article

      Opinion: U.S. Biologics And Biosimilars Need Distinguishable Names

      Apr 23, 2019

      Creating distinguishable nonproprietary names for biologics and their biosimilars will help ensure that patients get the right medications and will be useful for identifying adverse events more readily.

      5 min read

    • Article

      Opinion: Companies Must Responsibly Manufacture The Antimicrobials Society Needs

      Jan 30, 2020

      Providing access to antibiotics and other antimicrobials while reducing resistance to these medicines presents a dual manufacturing challenge: ensuring a cost-effective supply while minimizing their emission into the environment.

      4 min read

    • Article

      The Natural Cancer-fighters

      May 24, 2020

      The Natural Cancer-fighters
      8 min read

    • Article

      Opinion: Drug Sensitivity And Resistance Testing Could Make ‘Right To Try’ A Real Thing

      Oct 9, 2018

      There's no catalog of available drugs that can help patients pursuing #RightToTry options. An updated technique once developed for cancer might match patients with experimental drugs.

      3 min read

    • Article

      Opinion: A Quantum Of Innovation And The Incentives To Match

      Mar 7, 2019

      Modest tweaks to drugs, what some dismiss as "merely incremental," can represent real and compelling advances for patients and offer great value over time.

      9 min read

    • Article

      The Next Naloxone? Companies, Academics Search For Better Overdose-reversal Drugs

      Apr 10, 2018

      ATLANTA — Dr. Nora Volkow has heard a frightening scenario play out around the country. People are administering naloxone to synthetic opioid drug users who have overdosed. But the antidote doesn’t work well. So they give another dose. And it’s only

      5 min read

    • Article

      Update Essential Medicines Lists To Curb Resistance

      Nov 21, 2020

      THE World Health Organization (WHO) introduced an essential medicine list in 1977. The aim was to help countries prioritise which medicines to make available for public use. Every two years the WHO publishes a model list which countries use to develo

      3 min read

    • Article

      The Case For Drug Repurposing

      Nov 9, 2020

      Dr Markus Depfenhart, a specialist in plastic and aesthetic surgery According to the WHO, as of 14 July 2020, there have been more than 13 million confirmed cases of COVID-19 globally, and close to 600 000 deaths. We are in dire need of strategies to

      2 min read

    • Article

      Why Doctors Trust Drugs That Are Deadly

      May 23, 2021

      Doctors trust a new drug. After all, it’s gone through rigorous and expensive safety tests, there are reassuring studies that demonstrate the drug is effective—even if they have been paid for by the drug company—and salesmen will reward a prescriptio

      5 min read

    • Article

      Enzyme Discovery May Lead To New Diabetes And Obesity Drugs

      Aug 15, 2018

      Discoveries about a special enzyme could pave the way for new drugs to treat diabetes and obesity, research shows. The study also finds, however, that certain existing cancer drugs meant to inhibit the enzyme don’t work as well as previously thought.

      2 min read

    • Article

      How To Catch A Sports Cheat

      Sep 5, 2019

      How To Catch A Sports Cheat
      3 min read

    • Article

      The Drug Cascade

      Jun 24, 2017

      The Drug Cascade
      8 min read

    Reviews for Analogue-based Drug Discovery III

    3.5/5

    8 ratings3 reviews

    What did you think?

    Tap to rate

    Review must be at least 10 words

    • 4/5
      Too tired is a made up story of Noah's ark. As the flood is coming and all the animals are boarding Noah realizes they are missing the sloths. The sloths being unaware and lazy are too tired and asleep in the tree. Eventually all the animals aboard the ark (minus the cats) helps retrieve the sloths and complete Noah's list. Like many stories containing animals the author takes the opportunity to introduce many new adjectives, verbs, and vocab to students. In this particular book many words such as screeched, bleated, trumpeted, and howled are introduced to the student's vocabulary. This also makes students use context clues and prior knowledge to understand new words.
    • 4/5
      I thought that this was a cute book and it explained the story of Noah's Ark. It could be nice to read to preferably a catholic school while learning the story of Noah. The students would enjoy the book because it allows for the teacher to make sounds of the different animal noises.
    • 4/5
      I am not religious, but I am crazy about sloths! I loved that all the animals banded together (except the cats, of course) to help get the apathetic sloths on Noah's Ark. This would be a great read to a young Sunday school class.